This suggests that MYB-TR activates the G1/S cell cycle checkpoint and could explain why MYB-TR Hoxb8-FL.MS5 cells have a slow growth rate in vitro, and MYB-TR is unable to induce leukemia in vivo without KO of Cdkn2a. The gene discussed is CDKN2A; the disease is leukemia.